Victory Capital Management
AZR icon

Victory Capital Management’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Victory Capital Management’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2
Closed -$2K – 2511
2020
Q1 		$2K Buy
+2
New +$2.14K ﹤0.01% 3480
2019
Q4 		– Sell
-2
Closed -$2K – 2636
2019
Q3 		$2K Buy
+2
New +$2.13K ﹤0.01% 3612

Other funds holding AZR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Raffa Wealth Management
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Victory Capital Management's AZR Position: Q2 2020 in Review

Victory Capital Management sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q2 2020, closing a stake of 2 shares — an estimated $2K sold.

Victory Capital Management first reported a position in AZR in Q3 2019 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 11 funds tracked by Wall St. Rank hold AZR as of Q2 2020.

  • Victory Capital Management reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 2 Azora Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $2K.
  • Victory Capital Management first reported a position in Azora Therapeutics, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Azora Therapeutics, Inc. Common Stock position peaked at $2K in Q1 2020.
  • 11 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.